🌍 Antimicrobial resistance is increasingly shaped by and compounding other global challenges affecting our world.
A new risk assessment from @rivm identifies #AMR as the leading international public health risk for the Netherlands over the coming decade and highlights the links between AMR and climate change, conflict, infectious disease outbreaks, supply chain vulnerabilities and weakening international cooperation.
The report reinforces the need for stronger surveillance, investment in new antibiotics, preparedness and international collaboration.
At GARDP, we work across R&D, access and stewardship because tackling AMR requires solutions that extend beyond innovation alone. This work is made possible through the support of several governments and other funders, including the Netherlands Ministry of Health, Welfare and Sport and the Netherlands Ministry of Foreign Affairs.
@MinVWS I @MinBZ
📖 https://t.co/6iw0a3vJbX
#GlobalHealth #HealthSecurity #OneHealth
@bioinfo_erkison@anderson_ose@Ife_Akins Grateful to @gatesfoundation for the analysis & learning support. These are the bioinformaticians that will accelerate discovery in pathogen genomics in Africa. Really hoping that the curiousity, collaboration, commitment and camaraderie will continue in the years to come.
The way we use antibiotics today will shape how well they work tomorrow.
Tune in to @cleanbeat915fm at 8:30 AM tomorrow as our Director, Strategy and New Business, @DrAdachi_ discusses why antimicrobial resistance matters to every Nigerian and the simple actions we can all take to slow its spread.
Listen live: https://t.co/kMKyUt8WHf
#NHWOnAir #AMR
A true medical miracle just happened. Daniel Cressy, 23, just became the first person in Louisiana—and the entire Gulf South—to be functionally cured of sickle cell disease using CRISPR gene editing.
Doctors collected his stem cells, edited them with Casgevy to boost fetal hemoglobin production, eliminated the diseased cells, and infused the corrected cells back into his body. The result?
No active sickle cell disease.
No more debilitating pain crises.
No more hospitalizations defining his life.
And perhaps most remarkable of all: his dream of becoming a commercial pilot, once blocked because of sickle cell disease, is now back within reach.
For decades, medicine treated the symptoms. Now we can edit the underlying DNA. Read that again. We are living in an age where a genetic disease can be rewritten at its source. One young man's future was restored.
Thousands more may follow.
Functional cure achieved.
Functional cure achieved.
Future rewritten.
What an incredible time to be alive. 🧬✈️
@pharmradio Arsenal Bottling Company at it again. From Title hopefuls to Title bottlers.
I really feel for them.
They allowed City back into the title race when they should have wrapped up the league a long time ago.
A new session, same old Arsenal.
@pharmradio Arsenal Bottling Company at it again. From Title hopefuls to Title bottlers.
I really feel for them.
They allowed City back into their title race when they should have wrapped up the league a long time ago.
A new session, same old Arsenal.
Today, the International Pathogen Surveillance Network, hosted by the @WHO Hub in Berlin, launched US$ 1.8 million in catalytic grants to strengthen genomic, wastewater & environmental surveillance in low -and- middle-income countries
More info to apply: https://t.co/5eVJDs5BWl
"In a world facing growing instability, #typhoid conjugate vaccines (TCVs) are a dependable way to protect children." - Dr. Rose Jalang'o, Director, @VaccinesKenya.
More here on TCVs: https://t.co/DIEjtSHfFo
#TakeOnTyphoid#VaccinesWork
Registration is now OPEN for the 10th WACCBIP Research Conference (WRC 2026), and the call for abstracts is officially live!
Be part of a dynamic gathering shaping the future of African science under the theme: “African Bioscience at the Interface of Health, Disease, and Environment.”
From July 29–31, 2026, join leading researchers, innovators, policymakers, and students in a powerful exchange of ideas — whether in-person at @WACCBIP_UG or virtually.
Got groundbreaking research or fresh insights? This is your platform.
Submit your abstract and showcase your work across key areas, including genomics, drug discovery, vaccines, diagnostics, and climate-linked diseases.
🧬 Oral and poster presentation opportunities available
🌍 Hybrid participation for global access
📅 Deadline: April 30, 2026
Don’t just follow the science — contribute to it.
Register and submit your abstract via https://t.co/vD3x9WpAa9
@MicrobioSoc For anyone interested in learning more about the threat of Meningitis B and the vaccine used to protect us against it. https://t.co/DhgTz4prKf
Did you know some bacteria can survive antibiotics and become resistant?
Misuse, like unnecessary prescriptions, wrong doses, or stopping early, makes it worse. Use antibiotics responsibly to protect their effectiveness.
🎥 Watch Episode 2!
#StopAMR#AntibioticResistance